Magnetic Resonance Imaging of the Neuroprotective Effect of Xaliproden in Rats

Lemaire L, Fournier J, Ponthus C, et al. Magnetic resonance imaging of the neuroprotective effect of xaliproden in rats. Invest Radiol 2002;37:321–327. RATIONALE AND OBJECTIVES. The neurotrophic effect of Xaliproden has been followed using sequential cerebral magnetic resonance imaging (MRI) in rats...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Investigative radiology 2002-06, Vol.37 (6), p.321-327
Hauptverfasser:	LEMAIRE, LAURENT, FOURNIER, JACQUELINE, PONTHUS, CHRISTIAN, LE FUR, YANN, CONFORT-GOUNY, SYLVIANE, VION-DURY, JEAN, KEANE, PETER, COZZONE, PATRICK J
Format:	Artikel
Sprache:	eng
Schlagworte:	Alzheimer Disease Alzheimer Disease - chemically induced Alzheimer Disease - drug therapy Alzheimer Disease - pathology Animals Bioengineering Brain Brain - drug effects Brain - pathology Choline O-Acetyltransferase Choline O-Acetyltransferase - analysis Choline O-Acetyltransferase - antagonists & inhibitors Disease Models, Animal Enzyme Inhibitors Imaging Life Sciences Magnetic Resonance Imaging Male Medication Naphthalenes Naphthalenes - pharmacology Naphthalenes - therapeutic use Neuroprotective Agents Neuroprotective Agents - pharmacology Neuroprotective Agents - therapeutic use Pharmaceutical sciences Pyridines Pyridines - pharmacology Pyridines - therapeutic use Rats Rats, Sprague-Dawley Time Factors Vincristine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!